Home / Stocks / CPRX

CPRX insider trading

CATALYST PHARMACEUTICALS, INC. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
0
Bought · 24 mo
$0
Buys · last 90 days
0 · $0
Most recent buy

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-08-28Miller Steve
Chief Op. & Scientific Officer
Sold115,000$20.28$2.3M
2025-06-10MCENANY PATRICK J
Director
Sold171,748$26.11$4.5M
2025-06-03Daly Richard J
President and CEO
Sold70,000$24.86$1.7M
2025-05-15INGENITO GARY
Chief Med. & Reg. Officer
Sold244,000$23.67$5.8M
2025-03-07INGENITO GARY
Chief Med. & Reg. Officer
Sold180,096$21.67$3.9M
2025-03-05Elsbernd Brian
Chief Compliance/Legal Officer
Sold53,255$22.93$1.2M
2024-12-11Miller Steve
Chief Op. & Scientific Officer
Sold50,000$21.93$1.1M
2024-11-21MCENANY PATRICK J
Director
Sold170,845$21.23$3.6M
2024-11-15MCENANY PATRICK J
Director
Sold92,500$22.98$2.1M
2024-11-13MCENANY PATRICK J
Director
Sold492,000$23.39$11.5M

See CPRX on the chart

Every insider buy and sell for CPRX plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.